Importantly, we focused on genes involved in NAFLD (including IL-6, BID, and PRKAA2), and HIF-1 (including IL-6, HIF-1, and HMOX1) signaling pathways. This evidence concerns the gene PRKAA2 and metabolic dysfunction-associated steatotic liver disease.